A single 2 g oral dose of extended-release azithromycin for treatment of gonococcal urethritis
Open Access
- 19 June 2014
- journal article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 69 (11), 3116-3118
- https://doi.org/10.1093/jac/dku221
Abstract
We treated gonococcal urethritis in men with a single 2 g dose of azithromycin extended-release formulation (azithromycin-SR) to determine its microbiological outcomes and tolerability. We enrolled 189 Japanese men with gonococcal urethritis between April 2009 and December 2013. The patients were given a single 2 g dose of azithromycin-SR. Microbiological efficacy was evaluated by the results of the post-treatment molecular testing of Neisseriagonorrhoeae. MIC testing was performed only for pretreatment isolates of N. gonorrhoeae collected from the patients. We evaluated 130 patients for microbiological outcomes. Of these patients, 122 (93.8%) were judged to be microbiologically cured on the basis of negative test results. All isolates for which the azithromycin MICs were ≤0.25 mg/L were eradicated, whereas 5 of 12 isolates for which the MICs were 1 mg/L persisted after the treatment. Forty-six adverse events occurred in 41 patients. However, all adverse events were classified as mild. The eradication rate of N. gonorrhoeae was 93.8% in men with gonococcal urethritis treated with a single 2 g dose of azithromycin-SR. The breakpoint MIC of a 2 g dose of azithromycin-SR for gonococcal urethritis associated with clinical treatment failures appeared to be 1 mg/L. With regard to side effects of higher doses of azithromycin, the 2 g dose of azithromycin-SR appeared to improve tolerability. However, the widespread use of a high-dose regimen of azithromycin might lead to the development of further resistance to azithromycin.Keywords
This publication has 16 references indexed in Scilit:
- Ceftriaxone-ResistantNeisseria gonorrhoeae, JapanEmerging Infectious Diseases, 2011
- Azithromycin in the treatment of infection with Neisseria gonorrhoeaeSexually Transmitted Infections, 2010
- Emergence of High Level Azithromycin-Resistant Neisseria gonorrhoeae Strain Isolated in ArgentinaSexually Transmitted Diseases, 2009
- Update on the Management of Gonorrhea in Adults in the United StatesClinical Infectious Diseases, 2007
- Comparative Pharmacokinetics of Azithromycin in Serum and White Blood Cells of Healthy Subjects Receiving a Single-Dose Extended-Release Regimen versus a 3-Day Immediate-Release RegimenAntimicrobial Agents and Chemotherapy, 2007
- Fluoroquinolone Treatment Failure in GonorrheaSexually Transmitted Diseases, 1997
- A Clinical Isolate of Neisseria gonorrhoeae With In Vitro Resistance to Erythromycin and Decreased Susceptibility to AzithromycinSexually Transmitted Diseases, 1996
- Drugs of Choice for the Treatment of Uncomplicated Gonococcal InfectionsClinical Infectious Diseases, 1995
- Is an objective assessment of antibiotic therapy in exacerbations of chronic bronchitis possible?Journal of Antimicrobial Chemotherapy, 1993
- Evaluation of New Anti-Infective Drugs for the Treatment of Uncomplicated Gonorrhea in Adults and AdolescentsClinical Infectious Diseases, 1992